23 completed, 2 unknown, 1 withdrawn. 13 Not applicable, 9 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 13 | Completed 10, Unknown 2, Withdrawn 1 |
| Phase 2 | 9 | Completed 9 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 1 | Completed 1 |
Follow Amorepacific Corporation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex HTGT compound, Placebo - Body Fat | Not applicable | Unknown | Amorepacific Corporation | 100 | 2023-11-17 | 2024-09-24 |
| The Role of Red Flavonoid in Photoaging skin biopsy - Photoaging of Skin, Skin Aging | Not applicable | Withdrawn | Johns Hopkins University | 2023-10-01 | 2023-12-19 | |
| Evaluated the Efficacy and Safety of APCP on Hair Health APCP I, APCP II, Placebo - Hair Damage | Not applicable | Completed | Amorepacific Corporation | 150 | 2023-03-16 | 2024-05-22 |
| Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1 GTB1, Placebo - Body Fat | Not applicable | Completed | Amorepacific Corporation | 100 | 2022-10-28 | 2024-05-22 |
| Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation GTE, Placebo - Blood Sugar | Not applicable | Unknown | Amorepacific Corporation | 84 | 2022-08-08 | 2024-09-19 |
| Clinical Trial to Evaluate of Efficacy and Safety of Ginsengberry Concentrate on Fatigue. Ginsengberry concentrate, Placebo - Fatigue | Not applicable | Completed | Amorepacific Corporation | 88 | 2021-12-13 | 2023-05-26 |
| Efficacy and Safety of AP Collagen Peptide on the Skin AP collagen peptide, Placebo - Dry Skin | Not applicable | Completed | Amorepacific Corporation | 54 | 2020-12-15 | 2021-11-11 |
| Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1 GTB1, Placebo - Irritable Bowel Syndrome With Diarrhea | Not applicable | Completed | Amorepacific Corporation | 27 | 2020-11-01 | 2022-05-17 |
| Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet AP green tea extract - Blood Glucose, High | Not applicable | Completed | Amorepacific Corporation | 20 | 2020-07-24 | 2021-06-16 |
| Anti-pollution Effects of AP Green Tea Extracts AP green tea extracts - Respiratory Conditions Due to Unspecified External Agent | Not applicable | Completed | Amorepacific Corporation | 40 | 2019-05-03 | 2021-06-16 |
| Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA GABA, Placebo - Sleep Disturbance | Not applicable | Completed | Amorepacific Corporation | 60 | 2019-04-14 | 2021-09-20 |
| Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts Heukcha Extracts, Placebo - Triglycerides High | Not applicable | Completed | Amorepacific Corporation | 100 | 2019-04-03 | 2021-06-16 |
| CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis PAC-14028 cream 1.0%, PAC-14028 cream Vehicle - Atopic Dermatitis | Phase 3 | Completed | Amorepacific Corporation | 240 | 2016-11-01 | 2018-11-20 |
| Effects of Green Tea on Body Weight Reduction and Gut Microbiota Green tea - Obesity | Not applicable | Completed | Seoul National University Hospital | 120 | 2016-03-20 | 2018-05-25 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis PAC-14028 Cream 0.1%, PAC-14028 Cream 0.3%, PAC-14028 Cream 1.0% - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | Amorepacific Corporation | 56 | 2016-03-01 | 2018-11-20 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis PAC-14028 cream 0.1%, PAC-14028 cream 0.3%, PAC-14028 cream 1.0% - Atopic Dermatitis | Phase 2 | Completed | Amorepacific Corporation | 192 | 2015-10-01 | 2016-09-20 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects PAC-14028, Vehicle - Healthy | Phase 1 | Completed | Amorepacific Corporation | 24 | 2014-11-01 | 2016-04-22 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea PAC-14028 cream 0.1%, PAC-14028 cream 0.3%, PAC-14028 cream 1.0% - Rosacea | Phase 2 | Completed | Amorepacific Corporation | 216 | 2014-10-01 | 2016-09-20 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus PAC-14028 cream 0.1%, PAC-14028 cream 0.3%, PAC-14028 cream 1.0% - Skin Pruritus | Phase 2 | Completed | Amorepacific Corporation | 296 | 2014-10-01 | 2016-07-15 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis PAC-14028 cream 0.3%, PAC-14028 cream 1.0%, PAC-14028 cream vehicle - Seborrheic Dermatitis | Phase 2 | Completed | Amorepacific Corporation | 75 | 2014-02-01 | 2016-04-25 |
Showing 20 of 26. Sign in to see all of them.
Dermatitis, Atopic (4) · Rosacea (2) · Alopecia (1) · Dermatitis, Seborrheic (1) · Fatigue (1) · Hypertriglyceridemia (1) · Obesity (1) · Parasomnias (1)
N-(1-(3,5-difluoro-4-methanesulfonylaminophenyl)ethyl)-3-(2-propyl-6-trifluoromethylpyridine-3-yl)acrylamide (4) · Gene Expression (1) · Sodium Chloride (1) · Tea (1) · Valproic Acid (1) · gamma-Aminobutyric Acid (1)
South Korea (22)
BeomJoon Kim, Professor (3) · Kyuhan Kim, MD, PhD (2) · Miyoung Park, PhD (2) · Anna Chien, MD (1) · Belong Cho, MD, PhD (1) · Beomjoon Kim, MD, PhD (1) · Hae Kwang Lee, PhD (1) · Jae-Heon Kang, MD, PhD (1) · Jonghwa Roh, PhD (1) · Kyu-Han Kim, M.D.,Ph.D. (1) · Kyu-Han Kim, MD,Ph.D (1) · Kyung Lim Joa, Dr (1) · Kyung-Sang Yu, M.D., Ph.D. (1) · Oh Sang Kwon, Prof. (1) · Sang-Wook Song, M.D./Ph.D (1)
PMID 18046911, PMID 33229519, PMID 35499017, PMID 35620028, PMID 36252351